Relation between serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 levels, clinical status and growth parameters in prepubertal cystic fibrosis patients

Pediatrics International

Volumn 46, Issue 4, 2004, Pages 429-435

  Ozen, Metehan ^a,c   Cokugras, Haluk ^b   Ozen, Naile ^b   Camcioglu, Yildiz ^b   Akcakaya, Necla ^b  

^a INONU UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Ozalper Mah   (Turkey)

Author keywords

Cystic fibrosis; Growth parameters; IGF I; IGFBP 3; Prepuberty

Indexed keywords

ANABOLIC AGENT; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY HEIGHT; BODY MASS; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DEMOGRAPHY; FEMALE; GROWTH RATE; HEALTH STATUS; HUMAN; LUNG FUNCTION TEST; MALE; PREPUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; STATISTICAL ANALYSIS;

BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; RESPIRATORY FUNCTION TESTS;

EID: 4344640661     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2004.01925.x     Document Type: Article

References (35)

1. Rosenstein BJ, Zeitlin PL. Recent advances in cystic fibrosis. Curr. Opin. Pediatr. 1991; 3: 392-8.
2. Wilmott RW, Feidler MA. Recent advances in the treatment of cystic fibrosis. Pediatr Clin. North Am. 1994; 41: 431-51.
3. Boat TF, Boucher RC. Cystic fibrosis. In: Murray JF, Nadel JA (eds). Textbook of Respiratory Medicine. Saunders Company, Philadelphia, 1994; 1418-44.
4. Davis PB. Cystic fibrosis. Pediatr. Rev. 2001; 22: 257-64.
5. Doull JI. Recent advances in cystic fibrosis. Arch. Dis. Child 2001; 85: 62-6.
6. Cystic Fibrosis Foundation. Patient Registry 1995 Annual Data Report. Cystic Fibrosis Foundation, Bethesda, 1996.
7. Huseman CA, Colombo JL, Brooks M et al. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients. Pediatr. Pulmonol. 1996; 22: 90-5.
8. Levine JJ. Nutritional supplementation in cystic fibrosis: are all the patients candidates for aggressive therapy? J. Pediatr. Gastroenterol. Nutr. 1998; 27: 53-6.
9. Underwood LE. Growth retardation in chronic diseases: possible mechanisms. Acta Paediatr. 1999; 428 (Suppl.): 93-6.
10. Rechler MM. Insulin-like growth factor binding proteins. Vitam. Horm. 1993; 47: 1-114.
11. Schmid C. Insulin-like growth factors. Cell Biol. Int. 1995; 19: 445-57.
12. Hwa V, Oh Y, Rosenfeld RG. Insulin-like growth factors binding proteins: a proposed superfamily. Acta Paediatr. 1999; 428 (Suppl.): 37-45.
13. Kelley K, Oh Y, Gargosky S et al. Insulin-like growth factor binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 1996; 28: 619-37.
14. Neyzi O. Buyume ve gelisme bozukluklari. In: Neyzi O, ve Ertugrul T (eds). Cocuk Sagligi Ve Hastaliklari (Cilt. 1), Nobel Kitabevi, Istanbul 1989; 57-88 (in Turkish).
15. Polgar G, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. Saunders Company, Philadelphia, 1971; 88-107.
16. Shwachman H, Kulcyzcky LL. Studies made over a five to fourteen year period of 105 patients with cystic fibrosis. Am. J. Dis. Child 1958; 96: 6-15.
17. Laursen EM, Juul A, Lanng S et al. Diminished concentrations of IGF-I, body mass index, and clinical status in cystic fibrosis. Arch. Dis. Child 1995; 72: 494-7.
18. Taylor AM, Bush A, Thomson A et al. Relation between IGF-I, body mass index, and clinical status in cystic fibrosis. Arch. Dis. Child 1997; 76: 304-9.
19. Taylor AM, Thomson A, Bruce-Morgan C et al. The relationship between insulin, IGF-1 and weight gain in cystic fibrosis. Clin. Endocrinol. 1999; 51: 659-65.
20. Lebl J, Zahradnikova M, Bartosova J et al. IGF-I, IGFBP-3 in cystic fibrosis: a positive effect of antibiotic therapy and hyperalimentation. Acta Paediatr. 2001; 90: 868-72.
21. Juul A, Dalgaard P, Blum WF et al. Serum levels of IGF-I-IGFBP-3 in healthy infants, children, adolescents: The relation to IGF-1, IGF-2, IGFBP-1, IGFBP-2, age, sex, body mass index and pubertal maturation. J. Clin. Endo. Metab. 1995; 80: 2534-42.
22. Landon C, Rosenfeld RG. Short stature and pubertal delay in male adolescents with cystic fibrosis. Am. J. Dis. Child 1984; 138: 388-91.
23. Falorni A, Bini V, Cabiati G et al. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I, and IGF binding protein-3 in obese children and adolescents; relationship to gender, pubertal development, growth, insulin, and nutritional status. Metabolism 1997; 46: 862-71.
24. Clemmons DR, Underwood LE, Maes RN. Use of plasma somatomedin C/insulin like growth factor I measurement to monitor the response to nutritional repletion in malnourished patients. Am. J. Clin. Nutr. 1985; 41: 191-8.
25. Ripa P, Robertson I, Cowley D et al. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis. Clin. Endocrinol. 2002; 56: 383-9.
26. Patterson JM, Budd J, Goetz D, Warwick WJ. Family correlates of a 10 year pulmonary health trend in cystic fibrosis. Pediatrics 1993; 91: 383-9.
27. Kerem E, Reisman J, Corey M et al. Prediction of mortality in patients with cystic fibrosis. N. Engl. J. Med. 1992; 326: 1187-91.
28. Corey M, McLaughlin FJ, Williams M, Levison H. A comparasion of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J. Clin. Epidemiol. 1988; 41: 583-91.
29. Walker SA, Gozal D. Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings. J. Pediatr. Gastroenterol. Nutr. 1998; 27: 53-6.
30. Cystic Fibrosis Genetic Analysis Consortium. Worldwide survey of the ΔF508 mutation: report from the Cystic Fibrosis Genetic Analysis Consortium. Am. J. Hum. Genet. 1990; 47: 354-9.
31. Kerem B, Rommens JM, Buchanan J et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-80.
32. Kerem E, Corey M, Kerem B et al. The relation between genotype and phenotype in the cystic fibrosis: analysis of the most common mutation (ΔF508). N. Engl. J. Med. 1990; 323: 1517-22.
33. European Working Group on CF Genetics. Gradient of distribution in Europe of the major CF mutation and of its associated haplotypes. Hum. Genet. 1990; 85: 391-3.
34. Onay T, Zielenski J, Topaloglu O et al. Cystic fibrosis mutations and associated haplotypes in Turkish cystic fibrosis patients. Hum. Biol. 2001; 73: 191-203.
35. Morison S, Dodge JA, Cole TJ et al. Height and weight in cystic fibrosis: a cross sectional study. Arch. Dis. Child 1997; 77: 497-500.